Literature DB >> 17327223

Receptor-mediated endocytosis is not required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.

Susan L Kohlhaas1, Andrew Craxton, Xiao-Ming Sun, Michael J Pinkoski, Gerald M Cohen.   

Abstract

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is selectively toxic to tumor compared with normal cells. Other members of the TNF family of death ligands (TNF, CD95L) engage their respective receptors (TNF-R1 and CD95), resulting in internalization of receptor and ligand and recruitment of adaptor proteins to the caspase activation platform known as the death-inducing signaling complex (DISC). Recently, TNF-R1 and CD95 have been shown to induce apoptosis with an absolute requirement for internalization of their corresponding receptors in the formation of a DISC. We show that TRAIL and its receptors are rapidly endocytosed in a time- and concentration-dependent manner. Blockade of receptor internalization with hyperosmotic sucrose did not inhibit TRAIL-induced apoptosis but, rather, amplified the apoptotic signaling of TRAIL. Plate-bound and soluble TRAIL induced similar levels of apoptosis. Together these results suggest that neither ligand nor receptor internalization is required for TRAIL-induced apoptosis. Internalization of TRAIL is mediated primarily by clathrin-dependent endocytosis and also by clathrin-independent pathways. Inhibition of clathrin-dependent internalization by overexpression of dominant negative forms of dynamin or AP180 did not inhibit TRAIL-induced apoptosis. Consistent with the finding that neither internalization of TRAIL nor its receptors is required for transmission of its apoptotic signal, recruitment of FADD (Fas-associated death domain) and procaspase-8 to form the TRAIL-associated DISC occurred at 4 degrees C, independent of endocytosis. Our findings demonstrate that TRAIL and TRAIL receptor 1/2, unlike TNF-TNF-R1 or CD95L-CD95, do not require internalization for formation of the DISC, activation of caspase-8, or transmission of an apoptotic signal in BJAB type I cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327223     DOI: 10.1074/jbc.M700438200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Hepatocyte death: a clear and present danger.

Authors:  Harmeet Malhi; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  Ubiquitination-dependent regulation of signaling receptors in cancer.

Authors:  Wei-Chun Huangfu; Serge Y Fuchs
Journal:  Genes Cancer       Date:  2010-07

3.  Fas death receptor enhances endocytic membrane traffic converging into the Golgi region.

Authors:  Mauro Degli Esposti; Julien Tour; Sihem Ouasti; Saska Ivanova; Paola Matarrese; Walter Malorni; Roya Khosravi-Far
Journal:  Mol Biol Cell       Date:  2008-11-26       Impact factor: 4.138

Review 4.  Life and death by death receptors.

Authors:  Maria Eugenia Guicciardi; Gregory J Gores
Journal:  FASEB J       Date:  2009-01-13       Impact factor: 5.191

5.  TRAIL-death receptor endocytosis and apoptosis are selectively regulated by dynamin-1 activation.

Authors:  Carlos R Reis; Ping-Hung Chen; Nawal Bendris; Sandra L Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-03       Impact factor: 11.205

6.  Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.

Authors:  E W Duiker; E C F Dijkers; H Lambers Heerspink; S de Jong; A G J van der Zee; P L Jager; J G W Kosterink; E G E de Vries; M N Lub-de Hooge
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  Cell-surface galectin-3 confers resistance to TRAIL by impeding trafficking of death receptors in metastatic colon adenocarcinoma cells.

Authors:  N Mazurek; J C Byrd; Y Sun; M Hafley; K Ramirez; J Burks; R S Bresalier
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

8.  c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance.

Authors:  Jae J Song; Miroslaw Jerzy Szczepanski; So Young Kim; Joo-Hang Kim; Jee Young An; Yong Tae Kwon; Marco A Alcala; David L Bartlett; Yong J Lee
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

9.  Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell lines.

Authors:  Yuko Akazawa; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Alisan Kahraman; Maria Eugenia Guicciardi; Xue Wei Meng; Shigeru Kohno; Vijay H Shah; Scott H Kaufmann; Mark A McNiven; Gregory J Gores
Journal:  Gastroenterology       Date:  2009-03-09       Impact factor: 22.682

10.  Transformable DNA nanocarriers for plasma membrane targeted delivery of cytokine.

Authors:  Wujin Sun; Wenyan Ji; Quanyin Hu; Jicheng Yu; Chao Wang; Chenggen Qian; Gabrielle Hochu; Zhen Gu
Journal:  Biomaterials       Date:  2016-04-22       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.